Reports for HYDROCHLOROTHIAZIDE
Ingredient
HYDROCHLOROTHIAZIDE
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
PMS-IRBESARTAN-HCTZ | 12.5MG 300MG | TABLET | Actual shortage | 2023-04-06 | 2023-04-06 | 188954 |
PMS-IRBESARTAN-HCTZ | 25MG 300MG | TABLET | Resolved | 2017-04-20 | 2017-06-09 | 7373 |
PMS-IRBESARTAN-HCTZ | 25MG 300MG | TABLET | Resolved | 2017-06-23 | 2017-12-18 | 13709 |
PMS-IRBESARTAN-HCTZ | 25MG 300MG | TABLET | Resolved | 2017-09-07 | 2018-03-20 | 21562 |
PMS-IRBESARTAN-HCTZ | 25MG 300MG | TABLET | Resolved | 2019-06-28 | 2019-12-24 | 87971 |
PMS-IRBESARTAN-HCTZ | 25MG 300MG | TABLET | Resolved | 2023-10-02 | 2023-12-22 | 205611 |
PMS-IRBESARTAN-HCTZ | 25MG 300MG | TABLET | Actual shortage | 2024-02-07 | 2024-04-29 | 218776 |
IRBESARTAN-HCTZ | 12.5MG 150MG | TABLET | Resolved | 2017-03-14 | 2017-04-18 | 2304 |
IRBESARTAN-HCTZ | 12.5MG 150MG | TABLET | Resolved | 2017-05-09 | 2017-11-22 | 9705 |
IRBESARTAN-HCTZ | 12.5MG 150MG | TABLET | Resolved | 2019-01-16 | 2019-03-05 | 72434 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-IRBESARTAN/HCTZ | Discontinued | 2018-02-23 | 2018-07-17 | 40763 | ||
APO-IRBESARTAN/HCTZ | Discontinued | 2018-09-07 | 2018-09-15 | 60548 | ||
ACT CANDESARTAN/HCT | Discontinued | 2018-10-19 | 2018-10-19 | 65050 | ||
ACT CANDESARTAN/HCT | Discontinued | 2018-10-19 | 2018-10-19 | 65052 | ||
ACT IRBESARTAN/HCT | Discontinued | 2018-10-19 | 2018-10-19 | 65068 | ||
ACT IRBESARTAN/HCT | Discontinued | 2018-10-19 | 2018-10-19 | 65071 | ||
ACT IRBESARTAN/HCT | Discontinued | 2018-10-19 | 2018-10-19 | 65074 | ||
RAMIPRIL-HCTZ | Discontinued | 2018-12-21 | 2018-12-22 | 70392 | ||
APO-VALSARTAN/HCTZ | Discontinued | 2019-01-03 | 2019-01-03 | 71044 | ||
APO-VALSARTAN/HCTZ | Discontinued | 2019-01-03 | 2019-01-03 | 71048 |